Active Pharmaceutical Ingredient (API) Prequalified
M
Desogestrel (WHOAPI-479) manufactured by Hunan KYF Pharmaceutical Co. Ltd. has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.
24th Invitation to Manufacturers of Antimalarial Medicines to Submit an Expression of Interest (EOI) for Product Evaluation to the WHO Prequalification Unit (PQT)
M
The invitation to Manufacturers of Antimalarial Medicines to submit an Expre
23rd Invitation to Manufacturers of Antituberculosis Medicines to Submit an Expression of Interest (EOI) for Product Evaluation to the WHO Prequalification Unit
M
The Invitation to Manufacturers of Antituberculosis Medicines to submit an Expression of Interes
Active Pharmaceutical Ingredient (API) Prequalified
M
Lamivudine, manufactured by SMS Pharmaceuticals Limited, has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.
Post PQ Change Request for Prequalified & EUL-listed IVDs Process & Guidance Feedback Survey
IVD
The survey on the updated Post PQ Change Request process and PQDx 121 guidance shows that manufacturers are broadly satisfied with recent improvements to the system.
Active Pharmaceutical Ingredient (API) Prequalified
M
WHOAPI-429 (tenofovir disoproxil fumarate) manufactured by Styrax Pharma Pvt Ltd has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.
Position Note on Accessories Published
IVD
A Position Note on Accessories has been published by the Assessment of Medical Devices Team.
New WHO Public Inspection Reports (WHOPIRs) Published
IS
New WHO Public Inspection Reports (WHOPIRs) were published today: